339 related articles for article (PubMed ID: 23813961)
1. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation.
Pietiäinen V; Vassilev B; Blom T; Wang W; Nelson J; Bittman R; Bäck N; Zelcer N; Ikonen E
J Cell Sci; 2013 Sep; 126(Pt 17):3961-71. PubMed ID: 23813961
[TBL] [Abstract][Full Text] [Related]
2. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterization of two missense mutations in NDRG1 associated with Charcot-Marie-Tooth disease type 4D.
Li LX; Liu GL; Liu ZJ; Lu C; Wu ZY
Hum Mutat; 2017 Nov; 38(11):1569-1578. PubMed ID: 28776325
[TBL] [Abstract][Full Text] [Related]
4. The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.
Sorrentino V; Nelson JK; Maspero E; Marques ARA; Scheer L; Polo S; Zelcer N
J Lipid Res; 2013 Aug; 54(8):2174-2184. PubMed ID: 23733886
[TBL] [Abstract][Full Text] [Related]
5. Ndrg1 in development and maintenance of the myelin sheath.
King RH; Chandler D; Lopaticki S; Huang D; Blake J; Muddle JR; Kilpatrick T; Nourallah M; Miyata T; Okuda T; Carter KW; Hunter M; Angelicheva D; Morahan G; Kalaydjieva L
Neurobiol Dis; 2011 Jun; 42(3):368-80. PubMed ID: 21303696
[TBL] [Abstract][Full Text] [Related]
6. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
[TBL] [Abstract][Full Text] [Related]
7. A novel homozygous NDRG1 mutation in a Chinese patient with Charcot-Marie-Tooth disease 4D.
Chen B; Niu S; Chen N; Pan H; Wang X; Zhang Z
J Clin Neurosci; 2018 Jul; 53():231-234. PubMed ID: 29724652
[TBL] [Abstract][Full Text] [Related]
8. CMT4D (NDRG1 mutation): genotype-phenotype correlations.
Ricard E; Mathis S; Magdelaine C; Delisle MB; Magy L; Funalot B; Vallat JM
J Peripher Nerv Syst; 2013 Sep; 18(3):261-5. PubMed ID: 24028195
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor (NGF) and pro-NGF increase low-density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth.
Do HT; Bruelle C; Pham DD; Jauhiainen M; Eriksson O; Korhonen LT; Lindholm D
J Neurochem; 2016 Jan; 136(2):306-15. PubMed ID: 26484803
[TBL] [Abstract][Full Text] [Related]
10. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
Sorrentino V; Zelcer N
Curr Opin Lipidol; 2012 Jun; 23(3):213-219. PubMed ID: 22510808
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Neuregulin 1/ErbB Signaling in Charcot-Marie-Tooth Type 4D Disease.
Jiang LT; Chen YH; Huang JH; Tong WF; Jin LJ; Li LX
Mol Cell Biol; 2022 Jul; 42(7):e0055921. PubMed ID: 35708320
[TBL] [Abstract][Full Text] [Related]
12. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
Zelcer N; Hong C; Boyadjian R; Tontonoz P
Science; 2009 Jul; 325(5936):100-4. PubMed ID: 19520913
[TBL] [Abstract][Full Text] [Related]
13. Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).
Sorrentino V; Scheer L; Santos A; Reits E; Bleijlevens B; Zelcer N
J Biol Chem; 2011 Aug; 286(34):30190-9. PubMed ID: 21734303
[TBL] [Abstract][Full Text] [Related]
14. A novel NDRG1 mutation in a non-Romani patient with CMT4D/HMSN-Lom.
Piscosquito G; Magri S; Saveri P; Milani M; Ciano C; Farina L; Taroni F; Pareyson D
J Peripher Nerv Syst; 2017 Mar; 22(1):47-50. PubMed ID: 27982524
[TBL] [Abstract][Full Text] [Related]
15. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
[TBL] [Abstract][Full Text] [Related]
17. The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking.
Fedoseienko A; Wijers M; Wolters JC; Dekker D; Smit M; Huijkman N; Kloosterhuis N; Klug H; Schepers A; Willems van Dijk K; Levels JHM; Billadeau DD; Hofker MH; van Deursen J; Westerterp M; Burstein E; Kuivenhoven JA; van de Sluis B
Circ Res; 2018 Jun; 122(12):1648-1660. PubMed ID: 29545368
[TBL] [Abstract][Full Text] [Related]
18. CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL.
Bartuzi P; Billadeau DD; Favier R; Rong S; Dekker D; Fedoseienko A; Fieten H; Wijers M; Levels JH; Huijkman N; Kloosterhuis N; van der Molen H; Brufau G; Groen AK; Elliott AM; Kuivenhoven JA; Plecko B; Grangl G; McGaughran J; Horton JD; Burstein E; Hofker MH; van de Sluis B
Nat Commun; 2016 Mar; 7():10961. PubMed ID: 26965651
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap).
Do HT; Tselykh TV; Mäkelä J; Ho TH; Olkkonen VM; Bornhauser BC; Korhonen L; Zelcer N; Lindholm D
J Biol Chem; 2012 Apr; 287(16):12602-11. PubMed ID: 22378787
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site.
Martinelli L; Adamopoulos A; Johansson P; Wan PT; Gunnarsson J; Guo H; Boyd H; Zelcer N; Sixma TK
J Biol Chem; 2020 Sep; 295(39):13570-13583. PubMed ID: 32727844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
